| Name | Title | Contact Details |
|---|
Manufacturing and sale of industrial precision balls, rollers, cages and sheet metal parts used for bearing and other applications. Manufacturing and sale of ball screws, and large scale blowers.
At Flow, AI isnt just a feature—its the core of everything we do. We are transforming the wholesale insurance industry by building a futuristic insurance brokerage where AI powers every aspect of the experience. With advanced AI features already live in production and actively used by our brokers, we are pioneering Wholesale 3.0, equipping brokers with cutting-edge tools to provide unparalleled service. We are creating an ecosystem of AI agents designed to streamline processes and enhance decision-making in the insurance landscape. The industry relies heavily on text—emails, files, and documents—making Generative AI a perfect fit for solving its challenges. Flow leverages AI to deliver meaningful insights, deep analysis, and white-glove support for every transaction, no matter the deal size. By combining human expertise with Platformless AI, we are bringing back the art of wholesale insurance while eliminating the need for outdated portals. In the past seven months, weve grown 250% month-over-month(!) and are forecasting even more massive growth. Were a Series A startup with over $20M raised from top investors like Lightspeed, MunichRe Ventures, and industry angels.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Overview Honeybear Marketing LLC is a vertically integrated premium apple growing packing and marketing organization based in Washington State. We are Growers, Packers and Shippers of premium Washington State, Midwest and Southern Hemisphere apples and pears distributed throughout the United States and to international markets. With our "Premium Fresh Fruit" programs, we provide our customers with a dual hemisphere supply base in both the Northern and Southern Hemisphere. Today, through the exclusive arrangements with our growing partners in Chile and New Zealand, our customers enjoy the supply assurance of receiving premium fresh fruit year round. Honeybear Marketing is the sales and marketing company for 5 independently owned growing and packing entities in Washington State, Minnesota and Wisconsin. Our sales offices are located in Brewster WA, Yakima WA and Elgin, MN. Honeybear Marketing LLC is a wholly owned subsidiary of Wescott Agri Products